Announcements Trials

Browse Landscape

Phase

Phase 2 6 Phase NA 1 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Completed 46 Recruiting 14 Active not recruiting 13 Terminated 11 Withdrawn 4 Unknown 2 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Cyclophosphamide 21 fludarabine 17 Specimen Handling 13 Magnetic Resonance Spectroscopy 10 pembrolizumab 9 Nivolumab 9 Radiotherapy 7 Cisplatin 7 fludarabine phosphate 5 Injections 5 tislelizumab 4 daratumumab 4 Rituximab 4 Paclitaxel 4 Ipilimumab 4 Interleukin-2 4 Immune Checkpoint Inhibitors 4 Gemcitabine 4 Fluorouracil 4 Drug Therapy 4 Doxorubicin 4 Dexamethasone 4 Carboplatin 4 Biopsy 4 venetoclax 3 toripalimab 3 X-Rays 3 Radiosurgery 3 Platinum 3 Oxaliplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Not yet recruiting × olaparib × Clear all

NCT07090369 2025-07-29

LumOnate

Peter MacCallum Cancer Centre, Australia

Phase 1 Not yet recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡